Table 2.
Change from baseline in MAS scores for wrist flexor at 4 weeks (PPS).
| Liztox® Group (n = 88) |
Botox® Group (n = 85) |
Total (n = 173) |
|
|---|---|---|---|
| Baseline | |||
| n | 88 | 85 | 173 |
| Mean (SD) | 2.25 (0.44) | 2.32 (0.47) | 2.28 (0.45) |
| Median | 2.00 | 2.00 | 2.00 |
| Min, Max | 2.00, 3.00 | 2.00, 3.00 | 2.00, 3.00 |
| Week 4 | |||
| n | 88 | 85 | 173 |
| Mean (SD) | 1.11 (0.56) | 1.10 (0.52) | 1.11 (0.54) |
| Median | 1.00 | 1.00 | 1.00 |
| Min, Max | 0.00, 3.00 | 0.00, 2.00 | 0.00, 3.00 |
| Change from baseline at week 4 [1] | |||
| n | 88 | 85 | 173 |
| Mean (SD) | −1.14 (0.59) | −1.22 (0.59) | −1.18 (0.59) |
| Median | −1.00 | −1.00 | −1.00 |
| Min, Max | −3.00, 0.00 | −3.00, 0.00 | −3.00, 0.00 |
| Difference [97.5% confidence interval] * | 0.08 [−∞, 0.26] | ||
| p-value [2] | 0.3013 [b] | ||
SD = standard deviation, Min = minimum, Max = maximum. * If the upper boundary of the confidence interval was less than or equal to 0.45, the test group was proven non-inferior to the control group. [1] Change = week 4—baseline. [2] p-value for comparisons between treatment groups. * The level of significance was set at p < 0.05.